AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
SYNERGISTIC SUPPRESSION OF T-CELL RESPONSES BY CHLOROQUINE AND TACROLIMUS TO MINOR AND MAJOR HISTOCOMPATIBILITY ANTIGENS
Authors: SCHULTZ KR SU WN BADER S REMPEL J HAYGLASS KT
Citation: Kr. Schultz et al., SYNERGISTIC SUPPRESSION OF T-CELL RESPONSES BY CHLOROQUINE AND TACROLIMUS TO MINOR AND MAJOR HISTOCOMPATIBILITY ANTIGENS, Experimental hematology, 26(8), 1998, pp. 348-348
DIFFERENCES IN INVARIANT CHAIN (CD74) EXPRESSION BY BLASTS IN CHILDREN WITH ACUTE LEUKEMIAS
Authors: SCHULTZ KR DIX D WADSWORTH L MASSING B
Citation: Kr. Schultz et al., DIFFERENCES IN INVARIANT CHAIN (CD74) EXPRESSION BY BLASTS IN CHILDREN WITH ACUTE LEUKEMIAS, Experimental hematology, 26(8), 1998, pp. 386-386
BONE-MARROW BIOPSY AS PROGNOSTIC INDICATOR IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - ANOTHER OPINION - REPLY
Authors: SCHULTZ KR MASSING B SPINELLI JJ GAYNON PS WADSWORTH L
Citation: Kr. Schultz et al., BONE-MARROW BIOPSY AS PROGNOSTIC INDICATOR IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - ANOTHER OPINION - REPLY, Medical and pediatric oncology, 30(5), 1998, pp. 316-317
THE PHARMACOKINETICS OF ORAL CYCLOSPORINE-A (NEORAL) DURING THE FIRSTMONTH AFTER BONE-MARROW TRANSPLANTATION
Authors: SCHULTZ KR NEVILL TJ TOZE CL CORR T CURRIE C STRONG DK KEOWN PA
Citation: Kr. Schultz et al., THE PHARMACOKINETICS OF ORAL CYCLOSPORINE-A (NEORAL) DURING THE FIRSTMONTH AFTER BONE-MARROW TRANSPLANTATION, Transplantation proceedings, 30(5), 1998, pp. 1668-1670
IMMUNOSUPPRESSIVE THERAPY VS. BONE-MARROW TRANSPLANT FOR SEVERE APLASTIC-ANEMIA - REPLY
Authors: LAWLOR ER ANDERSON RA DAVIS JH FRYER CJH PRITCHARD SL ROGERS PCJ WU JK SCHULTZ KR
Citation: Er. Lawlor et al., IMMUNOSUPPRESSIVE THERAPY VS. BONE-MARROW TRANSPLANT FOR SEVERE APLASTIC-ANEMIA - REPLY, Journal of pediatric hematology/oncology, 19(6), 1997, pp. 533-534
IMMUNOSUPPRESSIVE THERAPY - A POTENTIAL ALTERNATIVE TO BONE-MARROW TRANSPLANTATION AS INITIAL THERAPY FOR ACQUIRED SEVERE APLASTIC-ANEMIA IN CHILDHOOD
Authors: LAWLOR ER ANDERSON RA DAVIS JH FRYER CJH PRITCHARD SL ROGERS PCJ WU JK SCHULTZ KR
Citation: Er. Lawlor et al., IMMUNOSUPPRESSIVE THERAPY - A POTENTIAL ALTERNATIVE TO BONE-MARROW TRANSPLANTATION AS INITIAL THERAPY FOR ACQUIRED SEVERE APLASTIC-ANEMIA IN CHILDHOOD, Journal of pediatric hematology/oncology, 19(2), 1997, pp. 115-123
THE LYSOSOMOTROPIC AMINES, CHLOROQUINE AND HYDROXYCHLOROQUINE - A POTENTIALLY NOVEL THERAPY FOR GRAFT-VERSUS-HOST DISEASE
Authors: SCHULTZ KR GILMAN AL
Citation: Kr. Schultz et Al. Gilman, THE LYSOSOMOTROPIC AMINES, CHLOROQUINE AND HYDROXYCHLOROQUINE - A POTENTIALLY NOVEL THERAPY FOR GRAFT-VERSUS-HOST DISEASE, Leukemia & lymphoma, 24(3-4), 1997, pp. 201-210
IMPORTANCE OF THE DAY-7 BONE-MARROW BIOPSY AS A PROGNOSTIC MEASURE OFTHE OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: SCHULTZ KR MASSING B SPINELLI JJ GAYNON PS WADSWORTH L
Citation: Kr. Schultz et al., IMPORTANCE OF THE DAY-7 BONE-MARROW BIOPSY AS A PROGNOSTIC MEASURE OFTHE OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Medical and pediatric oncology, 29(1), 1997, pp. 16-22
IMMUNE SUPPRESSION BY LYSOSOMOTROPIC AMINES AND CYCLOSPORINE ON T-CELL RESPONSES TO MINOR AND MAJOR HISTOCOMPATIBILITY ANTIGENS - DOES SYNERGY EXIST
Authors: SCHULTZ KR BADER S NELSON D WANG MD HAYGLASS KT
Citation: Kr. Schultz et al., IMMUNE SUPPRESSION BY LYSOSOMOTROPIC AMINES AND CYCLOSPORINE ON T-CELL RESPONSES TO MINOR AND MAJOR HISTOCOMPATIBILITY ANTIGENS - DOES SYNERGY EXIST, Transplantation, 64(7), 1997, pp. 1055-1065
ABILITY OF FILGRASTIM TO MOBILIZE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) TO SUPPORT INTENSIVE CHEMOTHERAPY IN RELAPSED PEDIATRIC TUMORS
Authors: ANDERSON RA CORR TR HEWITT LA DAVIS JA FRYER CJH HAND J PIRC L SCHULTZ KR
Citation: Ra. Anderson et al., ABILITY OF FILGRASTIM TO MOBILIZE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) TO SUPPORT INTENSIVE CHEMOTHERAPY IN RELAPSED PEDIATRIC TUMORS, Blood, 90(10), 1997, pp. 4196-4196
A PHASE-II STUDY OF FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) INFUSION SUPPORT FOR RELAPSED PEDIATRIC SOLID TUMORS BEINGTREATED WITH IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE)
Authors: ANDERSON RA CORR TR HEWITT LA DAVIS JH FRYER CJH HAND J PIRC L SCHULTZ KR
Citation: Ra. Anderson et al., A PHASE-II STUDY OF FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) INFUSION SUPPORT FOR RELAPSED PEDIATRIC SOLID TUMORS BEINGTREATED WITH IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE), Blood, 90(10), 1997, pp. 4197-4197
THE PHARMACOKINETICS OF ORAL CYCLOSPORINE-A (NEORAL) DURING THE FIRSTMONTH AFTER BONE-MARROW TRANSPLANTATION (BMT)
Authors: SCHULTZ KR NEVILL TJ TOZE CL CORR T CURRIE C STRONG DK KEOWN PA
Citation: Kr. Schultz et al., THE PHARMACOKINETICS OF ORAL CYCLOSPORINE-A (NEORAL) DURING THE FIRSTMONTH AFTER BONE-MARROW TRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 4434-4434
TREATMENT OF PROGRESSIVE INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA WITH INTENSIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: WATSON AL BARNETT MJ NANTEL SH TOZE CL NEVILL TJ HOGGE DE KLINGEMANN HG SUTHERLAND HJ CONNORS JM GASCOYNE RD SCHULTZ KR DAVIS JH NITTA JY SHEPHERD JD
Citation: Al. Watson et al., TREATMENT OF PROGRESSIVE INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA WITH INTENSIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4515-4515
GENETIC-ASPECTS OF DILATED CARDIOMYOPATHY
Authors: ORTIZLOPEZ R SCHULTZ KR TOWBIN JA
Citation: R. Ortizlopez et al., GENETIC-ASPECTS OF DILATED CARDIOMYOPATHY, Progress in pediatric cardiology, 6(1), 1996, pp. 71-82
CONCEPTUAL DESIGN OF LOW-ACTIVATION TARGET CHAMBER AND COMPONENTS FORTHE NATIONAL-IGNITION-FACILITY
Authors: STRECKERT HH SCHULTZ KR SAGER GT KANTNER RD
Citation: Hh. Streckert et al., CONCEPTUAL DESIGN OF LOW-ACTIVATION TARGET CHAMBER AND COMPONENTS FORTHE NATIONAL-IGNITION-FACILITY, Fusion technology, 30(3), 1996, pp. 448-451
INERTIAL CONFINEMENT FUSION TARGET INSERTION CONCEPTS FOR THE NATIONAL-IGNITION-FACILITY
Authors: LAUGHON GJ SCHULTZ KR
Citation: Gj. Laughon et Kr. Schultz, INERTIAL CONFINEMENT FUSION TARGET INSERTION CONCEPTS FOR THE NATIONAL-IGNITION-FACILITY, Fusion technology, 30(3), 1996, pp. 471-474
SYNERGY BETWEEN LYSOSOMOTROPIC AMINES AND CYCLOSPORINE-A ON HUMAN T-CELL RESPONSES TO AN EXOGENOUS PROTEIN ANTIGEN, TETANUS TOXOID
Authors: SCHULTZ KR NELSON D BADER S
Citation: Kr. Schultz et al., SYNERGY BETWEEN LYSOSOMOTROPIC AMINES AND CYCLOSPORINE-A ON HUMAN T-CELL RESPONSES TO AN EXOGENOUS PROTEIN ANTIGEN, TETANUS TOXOID, Bone marrow transplantation, 18(3), 1996, pp. 625-631
TARGET SUPPORT FOR INERTIAL CONFINEMENT FUSION
Authors: SCHULTZ KR
Citation: Kr. Schultz, TARGET SUPPORT FOR INERTIAL CONFINEMENT FUSION, Journal of fusion energy, 14(2), 1996, pp. 187-190
MAPPING OF A FAMILIAL DILATED CARDIOMYOPATHY GENE AND EVIDENCE FOR GENETIC-HETEROGENEITY
Authors: SCHULTZ KR GAJARSKI R PORTER P GOYTIA V BACHINSKI L ROBERTS R PIGNATELLI R TOWBIN JA
Citation: Kr. Schultz et al., MAPPING OF A FAMILIAL DILATED CARDIOMYOPATHY GENE AND EVIDENCE FOR GENETIC-HETEROGENEITY, Pediatric research, 39(4), 1996, pp. 204-204
A REVIEW OF THE VANCOUVER EXPERIENCE WITH BONE-MARROW TRANSPLANTATION(BMT) USING VOLUNTEER UNRELATED DONORS (VUD)
Authors: MICALLEF INM BARNETT MJ DAVIS JH SCHULTZ KR KLINGEMANN HG SHEPHERD JD SUTHERLAND HJ TOZE CL HOGGE DE PRITCHARD SL MUNN KJ BROCKINGTON DA FUNG HC ROGERS PCJ CHAN KW REECE DE PHILLIPS GL NANTEL SH
Citation: Inm. Micallef et al., A REVIEW OF THE VANCOUVER EXPERIENCE WITH BONE-MARROW TRANSPLANTATION(BMT) USING VOLUNTEER UNRELATED DONORS (VUD), Blood, 88(10), 1996, pp. 1046-1046
GENETIC-HETEROGENEITY IN FAMILIAL DILATED CARDIOMYOPATHY
Authors: SCHULTZ KR GAJARSKI RJ PIGNATELLI R GOYTIA V ROBERTS R BACHINSKI L TOWBIN JA
Citation: Kr. Schultz et al., GENETIC-HETEROGENEITY IN FAMILIAL DILATED CARDIOMYOPATHY, Biochemical and molecular medicine, 56(2), 1995, pp. 87-93
OBSTRUCTIVE LUNG-DISEASE IN CHILDREN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - EVALUATION WITH HIGH-RESOLUTION CT
Authors: SARGENT MA CAIRNS RA MURDOCH MJ NADEL HR WENSLEY D SCHULTZ KR
Citation: Ma. Sargent et al., OBSTRUCTIVE LUNG-DISEASE IN CHILDREN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - EVALUATION WITH HIGH-RESOLUTION CT, American journal of roentgenology, 164(3), 1995, pp. 693-696
REQUIREMENT FOR B-CELLS IN T-CELL PRIMING TO MINOR HISTOCOMPATIBILITYANTIGENS AND DEVELOPMENT OF GRAFT-VERSUS-HOST DISEASE
Authors: SCHULTZ KR PAQUET J BADER S HAYGLASS KT
Citation: Kr. Schultz et al., REQUIREMENT FOR B-CELLS IN T-CELL PRIMING TO MINOR HISTOCOMPATIBILITYANTIGENS AND DEVELOPMENT OF GRAFT-VERSUS-HOST DISEASE, Bone marrow transplantation, 16(2), 1995, pp. 289-295
CHLOROQUINE TREATMENT AFFECTS T-CELL PRIMING TO MINOR HISTOCOMPATIBILITY ANTIGENS AND GRAFT-VERSUS-HOST DISEASE
Authors: SCHULTZ KR BADER S PAQUET J LI W
Citation: Kr. Schultz et al., CHLOROQUINE TREATMENT AFFECTS T-CELL PRIMING TO MINOR HISTOCOMPATIBILITY ANTIGENS AND GRAFT-VERSUS-HOST DISEASE, Blood, 86(11), 1995, pp. 4344-4352
SYNERGY OF CHLOROQUINE AND CYCLOSPORINE-A IN-VITRO ON T-CELL RESPONSES TO MINOR HISTOCOMPATIBILITY ANTIGEN AND TETANUS TOXOID
Authors: NELSON D BADER S SCHULTZ KR
Citation: D. Nelson et al., SYNERGY OF CHLOROQUINE AND CYCLOSPORINE-A IN-VITRO ON T-CELL RESPONSES TO MINOR HISTOCOMPATIBILITY ANTIGEN AND TETANUS TOXOID, Blood, 86(10), 1995, pp. 882-882
Risultati: 1-25 | 26-45